Adage Capital Partners’s Integra LifeSciences IART Stock Holding History

Adage Capital Partners’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-50,000	Closed	-$2.18M	–	914
2023 Q4	$2.18M	Buy	+50,000	New	+$1.97M	﹤0.01%	739
2019 Q4	–	Sell	-150,000	Closed	-$9.01M	–	737
2019 Q3	$9.01M	Sell	150,000 -150,000	-50%	-$8.94M	0.02%	541
2019 Q2	$16.8M	Sell	300,000 -50,000	-14%	-$2.57M	0.04%	404
2019 Q1	$19.5M	Buy	350,000 +200,000	+133%	+$10.2M	0.05%	383
2018 Q4	$6.76M	Sell	150,000 -100,000	-40%	-$5.49M	0.02%	570
2018 Q3	$16.5M	Sell	250,000 -150,000	-38%	-$9.32M	0.04%	452
2018 Q2	$25.8M	Buy	400,000 +100,000	+33%	+$6.19M	0.06%	345
2018 Q1	$16.6M	Sell	300,000 -15,000	-5%	-$786K	0.04%	441
2017 Q4	$15.1M	Buy	+315,000	New	+$15.4M	0.03%	492
2016 Q4	–	Sell	-350,000	Closed	-$14.4M	–	708
2016 Q3	$14.4M	Sell	350,000 -50,000	-13%	-$2.09M	0.04%	446
2016 Q2	$16M	Hold	400,000	–	–	0.04%	415
2016 Q1	$13.5M	Sell	400,000 -4,290	-1%	-$134K	0.04%	452
2015 Q4	$13.7M	Buy	404,290 +204,290	+102%	+$6.39M	0.04%	463
2015 Q3	$5.96M	Buy	+200,000	New	+$6.25M	0.02%	596

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Adage Capital Partners's IART Position: Q1 2024 in Review

Adage Capital Partners sold out of Integra LifeSciences (IART) in Q1 2024, closing a stake of 50,000 shares — an estimated $2.18M sold.

Adage Capital Partners first reported a position in IART in Q3 2015 and held it in 14 quarters. The position peaked at $25.8M in Q2 2018. 281 funds tracked by Wall St. Rank hold IART as of Q1 2024.

Adage Capital Partners reported no remaining Integra LifeSciences position as of Q1 2024 after selling out during the quarter.
Adage Capital Partners sold 50,000 Integra LifeSciences shares in Q1 2024, an estimated $2.18M.
Adage Capital Partners first reported a position in Integra LifeSciences in Q3 2015 and held it in 14 quarters.
Adage Capital Partners's Integra LifeSciences position peaked at $25.8M in Q2 2018.
281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2024.

Based on Adage Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.